Abbott Laboratories

Abbott is in the business of creating breakthrough products in medical devices, nutrition, diagnostics, and branded generic pharmaceuticals. Some of the company’s best-known healthcare brands include products you’re probably really familiar with like Pedialyte, Ensure, Similac, and Glucerna. Abbott is also a leader in diagnostics and a conglomerate you’ll want to keep your eye on.

$130.41
(as of Feb 10, 10:34 AM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ticker Information for Abbott Laboratories

Stock Price
$130.41
Ticker Symbol
ABT
Exchange
NYSE

Industry Information for Abbott Laboratories

Sector
Healthcare
Industry
Medical Devices

Company Description for Abbott Laboratories

Country
USA
Full Time Employees
114,000

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Fundamentals for Abbott Laboratories

Market Capitalization
$223,866,765,312
EBITDA
$10,824,999,936
Dividends per Share
$0
P/E Ratio
16.89
Forward P/E Ratio
25.06
Earnings per Share
$7.64
Earnings per Share Estimate Next Year
$5.67
Profit Margin
13.99%
Shares Outstanding
1,734,460,032
Percent Owned by Insiders
0.53%
Percent Owned by Institutions
77.55%
52-Week High
$132.50
52-Week Low
$98.72

Technical Indicators for Abbott Laboratories

50-Day Moving Average
$117.83
200-Day Moving Average
$111.78
RSI
65.58
2.66

Analyst Ratings for Abbott Laboratories

Strong Buy
13
Buy
8
Hold
6
Sell
0
Strong Sell
0

News About Abbott Laboratories

Feb 7, 2025, 4:56 PM EST
The last few weekends have been roiled by headlines. See more.
Feb 7, 2025, 8:45 AM EST
The FreeStyle Libre 3 system helped Nathan manage his diabetes. See more.
Feb 6, 2025, 8:48 PM EST
We recently compiled a list of the Jim Cramer Highlighted Buying Opportunities in 13 Stocks.In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against the other stocks Jim Cramer recently talked about. See more.
Feb 4, 2025, 8:30 PM EST
'One cupcake won't kill you,' 'I'm going to get diabetes just looking at that,' 'That person doesn't look like they have diabetes.' See more.
Feb 4, 2025, 11:27 AM EST
New survey shows 40 per cent of people living with diabetes have skipped or missed a doctor's appointment due to shame or stigma1 70 per cent of people living with diabetes said supportive comments from others can significantly boost their motivation to manage their condition1 Abbott launches film that highlights challenges of living life with diabetes See more.